Why the rejection of Novartis plea is a huge victory for India

The Supreme Court’s rejection of the petition of multinational drug company Novartis for a patent for its old-but-dressed-up blood cancer drug Glivec is a tremendous victory for the people of India and the developing world.

Read Full Story>>